A Nature Medicine review argues medicine is shifting from chronological age to biological clocks that measure aging across organs and more than 40 cell types from blood-based protein data.
Three major aging waves appear around ages 34, 60 and 78, while organ clocks show roughly a 10-year spread in aging pace among same-age people, linking faster organ aging to organ-specific disease risk.
More than 60,000 people in recent cell-clock research showed about 1 in 4 had accelerated aging in one cell type; old brain astrocytes were tied to a 12.6-fold higher Alzheimer's risk and nearly 40-fold risk in APOE4 carriers with two copies.
Brain and immune-system clocks emerged as the strongest survival signals over 15 to 17 years, suggesting they may act as master regulators of aging even when other organs age faster.
Clinical use is not yet standard, but the review says validation is advancing, a new Alzheimer's prevention trial will track p-tau217 and brain clocks, and organ- or cell-level tests could reach the market within a year if standardized.
If the brain is aging's 'master regulator,' can rejuvenating it reverse aging in the entire body?
Could AI predict your risk for Alzheimer's just by analyzing a photo of your face?
Plasma Proteomics-Based Aging Clocks: Transforming Biological Age Measurement and Personalized Medicine
Overview
Recent breakthroughs in plasma proteomics have transformed aging research by introducing advanced machine learning models that analyze thousands of blood proteins from large populations. These new proteomic clocks can noninvasively estimate the biological age of over 40 different cell types and multiple organs, revealing that aging is a highly varied process within the body. This marks a major step beyond older methods like DNA methylation clocks, offering a more detailed and dynamic view of how different parts of the body age. These innovations promise more accurate health predictions and open new possibilities for personalized medicine.